SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit ...Middle East

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, inclusive (the "Class Period"). A...

Hence then, the article about spry investors have opportunity to lead ars pharmaceuticals inc securities fraud lawsuit was published today ( Friday 07/08/2026 - 03:25 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit )

Also on site :

• Arrest made in connection to devastating Foster City condo fire
• ‘KPop Demon Hunters’ Has Led Billboard’s Top Soundtracks Chart for 54 Weeks: Only One Soundtrack Has Led Longer (Full List)
• Katey Sagal Recalls Becoming 'A Mother Again at 52'